TrialCritical care (London, England)2013

Early treatment with IgM-enriched intravenous immunoglobulin does not mitigate critical illness polyneuropathy and/or myopathy in patients with multiple organ failure and SIRS/sepsis: a prospective, randomized, placebo-controlled, double-blinded trial.

Richard Brunner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.